Guerbet
hideThis article has multiple issues. Please help or discuss these issues on the talk page. (Learn how and when to remove these template messages)
|
Guerbet (Euronext: GBT) is a France-based manufacturer of contrast agents used in medical imaging. The company was founded in 1926 by André Guerbet, the son of Marcel Guerbet who in 1901 discovered Lipiodol – the first iodinated X-ray contrast agent.[1]
In 2017 Guerbet’s revenues were €807.1 million. It employs over 2,700 people worldwide and has manufacturing facilities in France, Ireland, Canada, Macedonia, the United States and Brazil. The company’s headquarters are located in Villepinte, a suburb of Paris and its shares are included in the CAC Small stock index.
References[]
- ^ "Corporate history". Guerbet Group website. Retrieved 8 January 2019.
External links[]
Categories:
- Healthcare companies of France
- Health care companies established in 1926
- French companies established in 1926
- Companies listed on Euronext Paris
- French company stubs